MMP-9 | MMP-2 | VEGF-A | |
---|---|---|---|
HG B-cell lymphomas | 22.1% (13–35) | 16.9% (3–22) | 17.3% (11–23) |
LG B-cell lymphomas | 15.7% (11–27) | 4.2% (2–7) | 13.8% (12–17) |
HG T-cell lymphomas | 79.8% (56–89) | 38.4% (29–45) | 44.7% (38–48) |
LG T-cell lymphomas | 41.3% (25–63) | 30.2 (26–33) | 30.2% (18–37) |
Control lymph nodes | 4.2% (1–7) | 0.8% (0–2) | 0.8% (0–2) |